Spastic ataxia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:316226
Who is this for?
Show terms as
40Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Spastic ataxia (Orphanet code 316226) is a clinical grouping term that encompasses a spectrum of rare neurological disorders characterized by the combined presence of both spasticity (increased muscle tone and stiffness due to upper motor neuron dysfunction) and cerebellar ataxia (impaired coordination and balance due to cerebellar dysfunction). These conditions affect the central nervous system, primarily involving the corticospinal tracts (which control voluntary movement) and the cerebellum (which coordinates movement and balance). The combination of spastic paraplegia and cerebellar ataxia reflects overlapping neurodegeneration in these two motor systems. Patients with spastic ataxia typically present with progressive difficulty walking due to both stiffness and unsteadiness, impaired coordination of limbs, dysarthria (slurred speech), abnormal eye movements such as nystagmus, and hyperreflexia with extensor plantar responses. Additional features may include peripheral neuropathy, cognitive impairment, urinary dysfunction, and skeletal deformities depending on the specific genetic subtype. The severity and age of onset vary considerably across the different subtypes grouped under this umbrella term. Spastic ataxia includes multiple genetic subtypes with both autosomal recessive and autosomal dominant inheritance patterns, involving various genes such as MARS2 (SPAX3), KIF1C (SPAX2/SAX2), MTPAP (SPAX4), and AFG3L2 (SPAX5), among others. Charlevoix-Saguenay type spastic ataxia (ARSACS, caused by SACS gene mutations) is one of the best-characterized forms. There is currently no curative treatment for spastic ataxias. Management is supportive and symptomatic, including physical therapy, occupational therapy, antispasticity medications (such as baclofen or tizanidine), speech therapy, and assistive devices for mobility. Genetic counseling is recommended for affected families.

Also known as:

Inheritance

Variable

Can be inherited in different ways depending on the underlying gene

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗NORD ↗

FDA & Trial Timeline

1 event
Mar 2026At Home Use of Stimulation Suits for Managing MS Symptoms

Daphne Kos — NA

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Spastic ataxia.

View clinical trials →

No actively recruiting trials found for Spastic ataxia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Spastic ataxia community →

Specialists

Showing 25 of 40View all specialists →
LM
Laurent Servais, MD
Specialist
PI on 6 active trials1 Spastic ataxia publication
AM
André Mégarbané, MD
Specialist
PI on 1 active trial1 Spastic ataxia publication
MM
Maximilian Wiesenfarth, MD
Specialist
PI on 1 active trial
PP
Pierre Pollak, MD, PhD
JACKSONVILLE, FL
Specialist
PI on 2 active trials
DK
Daphne Kos
Specialist
PI on 1 active trial
AP
Alessandro Filla, MD, PhD
Specialist
PI on 1 active trial
MP
Massimo Pandolfo, MD, PhD
Specialist
PI on 1 active trial
FP
François Tison, MD, PhD
Specialist
PI on 1 active trial
OP
Odile Boespflug-Tanguy, MD, PhD
Specialist
PI on 1 active trial
BP
Broussolle Emmanuel, MD, PhD
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Spastic ataxia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Spastic ataxiaForum →

No community posts yet. Be the first to share your experience with Spastic ataxia.

Start the conversation →

Latest news about Spastic ataxia

Disease timeline:

New recruiting trial: At Home Use of Stimulation Suits for Managing MS Symptoms

A new clinical trial is recruiting patients for Spastic ataxia

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Spastic ataxia

What is Spastic ataxia?

Spastic ataxia (Orphanet code 316226) is a clinical grouping term that encompasses a spectrum of rare neurological disorders characterized by the combined presence of both spasticity (increased muscle tone and stiffness due to upper motor neuron dysfunction) and cerebellar ataxia (impaired coordination and balance due to cerebellar dysfunction). These conditions affect the central nervous system, primarily involving the corticospinal tracts (which control voluntary movement) and the cerebellum (which coordinates movement and balance). The combination of spastic paraplegia and cerebellar ataxia

Which specialists treat Spastic ataxia?

25 specialists and care centers treating Spastic ataxia are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.